The Vancouver-based ingredient maker—in partnership with Signum Biosciences—has completed studies on the efficacy and safety of it cannabigerol on human skin.
Cannabinoid ingredients are increasingly popular in personal care. And with its engineered yeast and fermentation process, the biotech company Amyris is now equipped to manufacture cannabigerol, or CBG, commercially.
